Essilor: Publication of the 2013 Interim Financial Report

  Essilor:Publication of the 2013 Interim Financial Report

Business Wire

CHARENTON-LE-PONT, France -- August 29, 2013

Regulatory News:

The Essilor International 2013 Interim Financial Report (Paris:EI) is being
published today.

The report comprises the interim consolidated financial statements, the
interim management report, the statement by the person responsible for the
interim financial report and the Auditors’ review report on the interim
consolidated financial statements.

It can be downloaded from the Company’s website,, in the
“Publications & Downloads” section, or by clicking on:

About Essilor

The world’s leading ophthalmic optics company, Essilor designs, manufactures
and markets a wide range of lenses to improve and protect eyesight. Its
corporate mission is to enable everyone around the world to access lenses that
meet his or her unique vision requirements. To support this mission, the
Company allocates more than €150 million to research and innovation every
year, in a commitment to continuously bring new, more effective products to
market. Essilor’s flagship brands are Varilux^®, Crizal^®, Definity^®,
Xperio^®, Optifog^TM and Foster Grant^®. It also develops and markets
equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of approximately €5 billion in 2012 and
employs around 50,700 people. It operates in some 100 countries with 22
plants, more than 400 prescription laboratories and edging facilities, as well
as several research and development centers around the world.

For more information, please visit

The Essilor share trades on the NYSE Euronext Paris market and is included in
the Euro Stoxx 50 and CAC 40 indices.

Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.


Investor Relations and Financial Communications
Phone: +33 (0)1 49 77 42 16
Press spacebar to pause and continue. Press esc to stop.